Outsourced Pharma Capacity Update Videos - Fill/Finish
-
Lonza Capacity Update January 2025: Fill/Finish
1/31/2025
Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.
-
Lifecore Biomedical Capacity Update January 2025: Fill/Finish
1/31/2025
Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics.
-
Jubilant HollisterStier Capacity Update January 2025: Fill/Finish
1/31/2025
From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision.
-
FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish
1/31/2025
Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project.
-
Alcami Capacity Update January 2025: Fill/Finish
1/31/2025
Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes.
-
Capacity Update January 2025: Fill/Finish
1/31/2025
This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges.
-
SMC Ltd. Capacity Update October 2024: Fill/Finish
10/25/2024
Partner with us to access the critical services that drive your success — supporting everything from technical and development batches to Phase 1 clinical trials and product launch.
-
PCI Pharma Services Capacity Update October 2024: Fill/Finish
10/25/2024
Jeff Clement, Executive Director of Technical Sales Drug Product Development and Manufacturing, outlines our global sterile fill-finish and lyophilization capabilities, investments, and expansions.
-
Novartis Contract Manufacturing Services Capacity Update October 2024: Fill/Finish
10/25/2024
Let us support your high-quality medicines with integrated offerings in mammalian drug substances and drug products, including our fill and finish services for vials, syringes, cartridges, and auto-injectors.
-
Lifecore Biomedical Services Capacity Update October 2024: Fill/Finish
10/25/2024
Our injectables CDMO expertise can support your molecule, with a team skilled in complex formulations, over 20 commercial products, a 40+ year regulatory history, and a new isolator filler capacity.